Evaxion A (EVAX) Shares Outstanding (Diluted Average) (2021 - 2023)
Evaxion A posted quarterly Shares Outstanding (Diluted Average) of $460.0 for Q2 2023, up 2.22% year-on-year from $450.0 in Q2 2022, and up 2.22% on a QoQ basis from $450.0 in Q2 2022.
Evaxion A (EVAX) has 3 years of Shares Outstanding (Diluted Average) data on file, last reported at $460.0 in Q2 2023.
- For the quarter ending Q2 2023, Shares Outstanding (Diluted Average) rose 2.22% year-over-year to $460.0; the trailing twelve-month figure through Jun 2023 stood at $460.0 (up 2.22% YoY), and the FY2021 full-year result was $230.0, changed N/A from the prior year.
- Shares Outstanding (Diluted Average) for Q2 2023 stood at $460.0, up from $450.0 in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $590.0 in Q2 2021 and bottomed at $230.0 in Q1 2021.
- The 3-year median for Shares Outstanding (Diluted Average) is $450.0 (2022), against an average of $396.0.
- Peak annual rise in Shares Outstanding (Diluted Average) reached 8.7% in 2022, while the deepest fall reached 23.73% in 2022.
- A 3-year view of Shares Outstanding (Diluted Average) shows it stood at $590.0 in 2021, then decreased by 23.73% to $450.0 in 2022, then advanced by 2.22% to $460.0 in 2023.
- The last three Shares Outstanding (Diluted Average) figures came in at $460.0 (Q2 2023), $450.0 (Q2 2022), and $250.0 (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 198.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 460.00 |
| Jun 30, 2022 | 450.00 |
| Mar 31, 2022 | 250.00 |
| Jun 30, 2021 | 590.00 |
| Mar 31, 2021 | 230.00 |